
The Evolving and Emerging Role of Plasma Biomarkers in Diagnosing and Monitoring Alzheimer Disease
Over the past few decades, the understanding of Alzheimer disease (AD) has shifted from a symptomatic focus to a biologically driven framework. Previously, AD was diagnosed based on observable symptoms like memory loss, often confirmed post-mortem through …